LauraENiklasonMD
Anesthesiology • New Haven, CTCritical Care Medicine
Professor, Anesthesiology, Yale University School of Medicine
Dr. Niklason is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Howard Ave
Yale Physicians Bldg
New Haven, CT 06519Phone+1 203-785-2140Fax+1 203-785-6414
Education & Training
Massachusetts General HospitalFellowship, Critical Care Medicine, 1996 - 1996- Massachusetts General HospitalResidency, Anesthesiology, 1992 - 1995
University of MichiganInternship, Internal Medicine, 1991 - 1992
University of Michigan Medical SchoolClass of 1991
Certifications & Licensure
NC State Medical License 1998 - 2025
CT State Medical License 2006 - 2024- American Board of Anesthesiology Anesthesiology
- American Board of Anesthesiology Critical Care Medicine
Publications & Presentations
PubMed
- 151 citationsSingle-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes.Neal G. Ravindra, Mia Madel Alfajaro, Victor Gasque, Nicholas C. Huston, Han Wan
Plos Biology. 2021-03-17 - 607 citationsRepair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function.Brigid L.M. Hogan, Christina E. Barkauskas, Harold A. Chapman, Jonathan A. Epstein, Rajan Jain
Cell Stem Cell. 2014-08-07 - 109 citationsQuantification of Extracellular Matrix Proteins from a Rat Lung Scaffold to Provide a Molecular Readout for Tissue EngineeringRyan C. Hill, Elizabeth A. Calle, Monika Dzieciatkowska, Laura E. Niklason, Kirk C. Hansen
Molecular & Cellular Proteomics. 2015-04-01
Press Mentions
‘It’s Spare Parts for People’: Blood Vessels Grown in a LabOctober 21st, 2024- Humacyte Announces Fourth Quarter and Year End 2022 Financial Results and Business UpdateApril 24th, 2023
- Humacyte, Inc. (NASDAQ:HUMA) Q4 2022 Earnings Call TranscriptMarch 30th, 2023
- Join now to see all
Grant Support
- Matrix And Bioreactors For Human Lung RegenerationNational Heart, Lung, And Blood Institute2012
- Lung Tissue EngineeringNational Heart, Lung, And Blood Institute2010–2012
- Biological Vascular GraftsNational Heart, Lung, And Blood Institute2006–2012
- Research Training In AnesthesiaNational Institute Of General Medical Sciences2009–2011
- Enabling Strategies For Growing Collagenous TissuesNational Institute Of Biomedical Imaging And Bioengineering2007–2010
- Novel Cellular Lifespan Extension For Tissue EngineeringNational Heart, Lung, And Blood Institute2006
- Novel Cellular Lifespan Extension For Tissue EngineeringNational Heart, Lung, And Blood Institute2005
- Arteries Engineered From Porcine Vascular CellsNational Heart, Lung, And Blood Institute2005
- Arteries Engineered From Porcine Vascular CellsNational Heart, Lung, And Blood Institute2002–2005
- Tissue Engineered Vascular ProsthesesNational Heart, Lung, And Blood Institute1998–2000
- Tissue Engineered Vascular ProsthesesNational Heart, Lung, And Blood Institute1996–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
